Back to Search Start Over

Racial disparities in inpatient clinical presentation, treatment, and outcomes in brain metastasis.

Authors :
McCray E
Waguia R
de la Garza Ramos R
Price MJ
Williamson T
Dalton T
Sciubba DM
Yassari R
Goodwin AN
Fecci P
Johnson MO
Chaichana K
Goodwin CR
Source :
Neuro-oncology practice [Neurooncol Pract] 2022 Jul 31; Vol. 10 (1), pp. 62-70. Date of Electronic Publication: 2022 Jul 31 (Print Publication: 2023).
Publication Year :
2022

Abstract

Background: Few studies have assessed the impact of race on short-term patient outcomes in the brain metastasis population. The goal of this study is to evaluate the association of race with inpatient clinical presentation, treatment, in-hospital complications, and in-hospital mortality rates for patients with brain metastases (BM).<br />Method: Using data collected from the National Inpatient Sample between 2004 and 2014, we retrospectively identified adult patients with a primary diagnosis of BM. Outcomes included nonroutine discharge, prolonged length of stay (pLOS), in-hospital complications, and mortality.<br />Results: Minority (Black, Hispanic/other) patients were less likely to receive surgical intervention compared to White patients (odds ratio [OR] 0.70; 95% confidence interval [CI] 0.66-0.74, p  < 0.001; OR 0.88; 95% CI 0.84-0.93, p  < 0.001). Black patients were more likely to develop an in-hospital complication than White patients (OR 1.35, 95% CI 1.28-1.41, p  < 0.001). Additionally, minority patients were more likely to experience pLOS than White patients (OR 1.48; 95% CI 1.41-1.57, p  < 0.001; OR 1.34; 95% CI 1.27-1.42, p  < 0.001). Black patients were more likely to experience a nonroutine discharge (OR 1.25; 95% CI 1.19-1.31, p  < 0.001) and higher in-hospital mortality than White (OR 1.13; 95% CI 1.03-1.23, p  = 0.008).<br />Conclusion: Our analysis demonstrated that race is associated with disparate short-term outcomes in patients with BM. More efforts are needed to address these disparities, provide equitable care, and allow for similar outcomes regardless of care.<br /> (© The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)

Details

Language :
English
ISSN :
2054-2577
Volume :
10
Issue :
1
Database :
MEDLINE
Journal :
Neuro-oncology practice
Publication Type :
Academic Journal
Accession number :
36659969
Full Text :
https://doi.org/10.1093/nop/npac061